52 related articles for article (PubMed ID: 15480830)
1. Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications.
Miermeister CP; Petersenn S; Buchfelder M; Fahlbusch R; Lüdecke DK; Hölsken A; Bergmann M; Knappe HU; Hans VH; Flitsch J; Saeger W; Buslei R
Acta Neuropathol Commun; 2015 Aug; 3():50. PubMed ID: 26285571
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 labeling index and Knosp classification of pituitary adenomas.
Yuhan L; Zhiqun W; Jihui T; Renlong P
Br J Neurosurg; 2024 Apr; 38(2):393-397. PubMed ID: 33905276
[TBL] [Abstract][Full Text] [Related]
3. Expression of Eag1 K+ channel and ErbBs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells.
del Pliego MG; Aguirre-Benítez E; Paisano-Cerón K; Valdovinos-Ramírez I; Rangel-Morales C; Rodríguez-Mata V; Solano-Agama C; Martín-Tapia D; de la Vega MT; Saldoval-Balanzario M; Camacho J; Mendoza-Garrido ME
Int J Clin Exp Pathol; 2013; 6(3):458-68. PubMed ID: 23413122
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of cyst/tumor volume ratio of pituitary adenoma for tumor cell proliferation.
Wu J; Zhang F; Huang Y; Wei L; Mei T; Wang S; Zeng Z; Wang W
BMC Med Imaging; 2024 Mar; 24(1):69. PubMed ID: 38515047
[TBL] [Abstract][Full Text] [Related]
5. Pituitary Adenomas and Invasiveness from Anatomo-Surgical, Radiological, and Histological Perspectives: A Systematic Literature Review.
Serioli S; Doglietto F; Fiorindi A; Biroli A; Mattavelli D; Buffoli B; Ferrari M; Cornali C; Rodella L; Maroldi R; Gasparotti R; Nicolai P; Fontanella MM; Poliani PL
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817110
[TBL] [Abstract][Full Text] [Related]
6. Nucleostemin and ASPP2 expression is correlated with pituitary adenoma proliferation.
Ma L; Chen ZM; Li XY; Wang XJ; Shou JX; Fu XD
Oncol Lett; 2013 Nov; 6(5):1313-1318. PubMed ID: 24179515
[TBL] [Abstract][Full Text] [Related]
7. Expression of laminin beta2: a novel marker of hypoxia in pituitary adenomas.
Bao Y; Yoshida D; Morimoto D; Teramoto A
Endocr Pathol; 2006; 17(3):251-61. PubMed ID: 17308362
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.
Pan LX; Chen ZP; Liu YS; Zhao JH
J Neurooncol; 2005 Aug; 74(1):71-6. PubMed ID: 16078111
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 in pituitary neoplasms: a review--part I.
Salehi F; Agur A; Scheithauer BW; Kovacs K; Lloyd RV; Cusimano M
Neurosurgery; 2009 Sep; 65(3):429-37; discussion 437. PubMed ID: 19687686
[TBL] [Abstract][Full Text] [Related]
10. Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.
de Aguiar PH; Aires R; Laws ER; Isolan GR; Logullo A; Patil C; Katznelson L
Neurol Res; 2010 Dec; 32(10):1060-71. PubMed ID: 20483025
[TBL] [Abstract][Full Text] [Related]
11. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E
Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830
[TBL] [Abstract][Full Text] [Related]
12. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
13. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody.
Lath R; Chacko G; Chandy MJ
Neurol India; 2001 Jun; 49(2):144-7. PubMed ID: 11447433
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
